The American Journal of Medicine
Volume 122, Issue 11 , Pages 977-991 , November 2009

An Umbrella Review: Corticosteroid Therapy for Adults with Acute Asthma

  • Jerry A. Krishnan, MD, PhD

      Affiliations

    • Department of Medicine, University of Chicago, Chicago, Illinois
    • Department of Health Studies, University of Chicago, Chicago, Illinois
    • Corresponding Author InformationRequests for reprints should be addressed to Jerry A. Krishnan, MD, PhD, The University of Chicago, 5841 S. Maryland Ave, MC 6076, Chicago, IL 60637
    • ,
  • Steven Q. Davis, MD, MS

      Affiliations

    • Department of Medicine, University of Chicago, Chicago, Illinois
    • ,
  • Edward T. Naureckas, MD

      Affiliations

    • Department of Medicine, University of Chicago, Chicago, Illinois
    • ,
  • Peter Gibson, MBBS

      Affiliations

    • Department of Respiratory and Sleep Medicine, Hunter Medical Research Institute, John Hunter Hospital, University of Newcastle, Newcastle, Australia
    • ,
  • Brian H. Rowe, MD, MSc

      Affiliations

    • Department of Emergency Medicine, University of Alberta, Canada

References 

  1. National Heart, Blood, and Lung Institute. National Asthma Education and Prevention Program (Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma). Bethesda, MD: National Institutes of Health; 2007;Publication No. 08-4051
  2. National Institutes of Health/National Heart, Lung, and Blood Institute. Data fact sheet, asthma statistics. January 1999. http://www.nhlbi.nih.gov/health/prof/lung/asthma/asthstat.pdfAccessed September 21, 2008
  3. Atmar RL, Guy E, Guntupalli KK, et al. Respiratory tract viral infections in inner-city asthmatic adults. Arch Intern Med. 1998;158:2453–2459
  4. Rosenstreich DL, Eggleston P, Kattan M, et al. The role of cockroach allergy and exposure to cockroach allergen in causing morbidity among inner-city children with asthma. N Engl J Med. 1997;336:1356–1363
  5. Friedman MS, Powell KE, Hutwagner L, et al. Impact of changes in transportation and commuting behaviors during the 1996 Summer Olympic Games in Atlanta on air quality and childhood asthma. JAMA. 2001;285:897–905
  6. Romieu I, Meneses F, Sienra-Monge JJ, et al. Effects of urban air pollutants on emergency visits for childhood asthma in Mexico City. Am J Epidemiol. 1995;141:546–553
  7. Galan I, Tobias A, Banegas JR, et al. Short-term effects of air pollution on daily asthma emergency room admissions. Eur Respir J. 2003;22:802–808
  8. Lemiere C, Bai T, Balter M, et al. Adult asthma consensus guidelines update 2003. Can Respir J. 2004;11(Suppl A):9A–18A
  9. Stellato C. Glucocorticoid actions on airway epithelial responses in immunity: functional outcomes and molecular targets. J Allergy Clin Immunol. 2007;120:1247–1263
  10. Rodrigo G, Rodrigo C. Corticosteroids in the emergency department therapy of acute asthma. Chest. 1999;116:285–295
  11. Manser R, Reid D, Abramson M. Corticosteroids for acute severe asthma in hospitalised patients. Cochrane Database Syst Rev. 2001;1:CD001740
  12. Rowe BH, Spooner CH, Ducharme FM, Bretzlaff JA, Bota GW. Early emergency department treatment of acute asthma with systemic corticosteroids. Cochrane Database Syst Rev. 2001;1:CD002178
  13. Rowe BH, Spooner CH, Ducharme FM, Bretzlaff JA, Bota GW. Corticosteroids for preventing relapse following acute exacerbations of asthma. Cochrane Database Syst Rev. 2007 July 18;13:CD000195
  14. Edmonds ML, Camargo CA, Saunders LD, et al. Inhaled steroids in acute asthma following emergency department discharge. Cochrane Database Syst Rev. 2000;3:CD002316
  15. McFadden ER, Kiser R, deGroot WJ, et al. A controlled study of the effects of single doses of hydrocortisone on the resolution of acute attacks of asthma. Am J Med. 1976;60:52–59
  16. Medical Research Council. Controlled trials of effect of cortisone acetate in status asthmaticus. Lancet. 1956;2:803–806
  17. Fanta CH, Rossing TH, McFadden ER. Glucocorticoids in acute asthma (A critical controlled trial). Am J Med. 1983;74:845–851
  18. Ratto D, Alfaro C, Sipsey J, et al. Are intravenous corticosteroids required in status asthmaticus?. JAMA. 1988;260:527–529
  19. Jones AM, Munavvar M, Vail A, et al. Prospective, placebo-controlled trial of 5 vs 10 days of oral prednisone in acute adult asthma. Respir Med. 2002;96:950–954
  20. Hasegawa T, Ishihara K, Takakura S, et al. Duration of systemic corticosteroids in the treatment of asthma exacerbation; a randomized study. Intern Med. 2000;794–797
  21. Cydulka RK, Emerman CL. A pilot study of steroid therapy after emergency department treatment of acute asthma: is a taper needed?. J Emerg Med. 1998;16:15–19
  22. Karan RS, Pandhi P, Behera D, et al. A comparison of non-tapering vs tapering prednisolone in acute exacerbation of asthma involving use of the low-dose ACTH test. Int J Clin Pharmacol Ther. 2002;40:256–262
  23. Hatton MQF, Vathenen AS, Allen MJ, et al. A comparison of abruptly stopping with tailing off oral corticosteroids in acute asthma. Respir Med. 1995;89:101–104
  24. O'Driscoll BR, Kalra S, Wilson M, et al. Double-blind trial of steroid tapering in acute asthma. Lancet. 1993;341:324–327
  25. Lederle FA, Pluhar RE, Joseph AM, Niewoehner DE. Tapering corticosteroid therapy following exacerbation of asthma (A randomized, double-blind, placebo-controlled trial). Arch Intern Med. 1987;147:2201–2203
  26. Lahn M, Bijur P, Gallagher EJ. Randomized clinical trial of intramuscular vs oral methylprednisolone in the treatment of asthma exacerbations following discharge from an emergency department. Chest. 2004;126:362–368
  27. Chan JS, Cowie RL, Lazarenko GC, et al. Comparison of intramuscular betamethasone and oral prednisone in the prevention of relapse of acute asthma. Can Respir J. 2001;8:147–152
  28. Schuckman H, DeJulius DP, Blanda M, et al. Comparison of intramuscular triamcinolone and oral prednisone in the outpatient treatment of acute asthma: a randomized controlled trial. Ann Emerg Med. 1998;31:333–338
  29. Structure of a Cochrane Review. http://www.cochrane.org/review/revstruc.htmAccessed February 19, 2005
  30. American Academy of Pediatrics: Policy Statement. Classifying Recommendations for Clinical Practice Guidelines. Pediatrics. 2004;114:874–877
  31. Lin RY, Pesola GR, Westfal RE, et al. Early parenteral corticosteroid administration in acute asthma. Am J Emerg Med. 1997;7:621–625
  32. Lin RY, Pesola GR, Bekalchuk L, et al. Rapid improvement in peak flow in asthmatic patients treated with parenteral methylprednisolone in the emergency department: a randomized controlled study. Ann Emerg Med. 1999;33:487–494
  33. Littenberg B, Gluck E. A controlled trial of methylprednisolone in the emergency treatment of acute asthma. N Engl J Med. 1986;314:150–152
  34. Rodrigo C, Rodrigo G. Early administration of hydrocortisone in the emergency room treatment of acute asthma: a controlled clinical trial. Respir Med. 1994;88:755–761
  35. Schneider SM, Piper A, Britton HL, et al. High-dose methylprednisolone as initial therapy in patients with acute bronchospasm. J Asthma. 1988;25:189–193
  36. Stein LM, Cole RP. Early administration of corticosteroids in emergency room treatment of acute asthma. Ann Intern Med. 1990;112:822–827
  37. Bowler SD, Mitchell CA, Armstrong JG. Corticosteroids in acute severe asthma: effectiveness of low doses. Thorax. 1992;47:584–587
  38. Engel T, Dirksen A, Frolund L, et al. Methylprednisolone pulse therapy in acute severe asthma: a randomized, double-blind study. Allergy. 1990;45:224–230
  39. Haskell RJ, Wong BM, Hansen JE. A double-blind, randomized clinical trial of methylprednisolone in status asthmaticus. Arch Intern Med. 1983;143:1324–1327
  40. Marquette CH, Stach B, Cardot E, et al. High dose and low dose systematic corticosteroids are equally efficient in acute severe asthma. Eur Respir J. 1995;8:22–27
  41. Harrison BD, Stokes TC, Hart GJ, et al. Need for intravenous hydrocortisone in addition to oral prednisolone in patients admitted to hospital with severe asthma without ventilatory failure. Lancet. 1986;1:181–184
  42. Guest JF, Davie AM, Ruiz FJ, et al. Switching asthma patients to a once-daily inhaled steroid improves compliance and reduces healthcare costs. Prim Care Respir J. 2005;14:88–98
  43. Krishnan JA, Riekert KA, McCoy JV, et al. Corticosteroid use after hospital discharge among high-risk adults with asthma. Am J Respir Crit Care Med. 2004;170:1281–1285
  44. Cooper WO, Hickson GB. Corticosteroid prescription filling for children covered by Medicaid following an emergency department visit or a hospitalization for asthma. Arch Pediatr Adolesc Med. 2001;155:1111–1115
  45. Williams LK, Pladevall M, Xi H, et al. Relationship between adherence to inhaled corticosteroids and poor outcomes among adults with asthma. J Allergy Clin Immunol. 2004;114:1288–1293
  46. Hoffman IB, Feil SB. Oral versus repository corticosteroid therapy in acute asthma. Chest. 1988;93:11–13
  47. Lee C-H, Lee C-J, Lan R-S, et al. Repository dexamethasone in the treatment of acute bronchial asthma. Changgeng Yi Xue Za Zhi. 1993;16:25–29
  48. Rowe BH, Bota GW, Fabris L, et al. Inhaled budesonide in addition to oral corticosteroids to prevent relapse following discharge from the emergency department: a randomized controlled trial. JAMA. 1999;281:2119–2126
  49. Brenner BE, Chavda KK, Camargo CA. Randomized trial of inhaled flunisolide versus placebo among asthmatic patients discharged from the emergency department. Ann Emerg Med. 2000;36:417–426
  50. Camargo CA MARC Investigators. Randomized trial of medium-dose fluticasone vs placebo after an emergency department visit for acute asthma. [abstract] J Allergy Clin Immunol. 2000;105(Pt 2):S262
  51. Sin DD, Man SF. Low-dose inhaled corticosteroid therapy and risk of emergency department visits for asthma. Arch Intern Med. 2002;164:1591–1595
  52. Blais L, Ernst P, Boivin J-F, Suissa S. Inhaled corticosteroids and the prevention of readmission to hospital of asthma. Am J Respir Crit Care Med. 1998;158:126–132
  53. Camargo CA, Smithline HA, Malice MP, et al. A randomized controlled trial of intravenous montelukast in acute asthma. Am J Respir Crit Care Med. 2003;167:528–533
  54. Silverman RA, Nowak RM, Korenblat PE, et al. Zafirlukast treatment for acute asthma: evaluation in a randomized, double-blind, multicenter trial. Chest. 2004;126:1480–1489
  55. Rowe BH, Wong E, Blitz S, et al. Adding long-acting beta-agonists to inhaled corticosteroids after discharge from the emergency department for acute asthma: a randomized controlled trial. Acad Emerg Med. 2007;14:833–840
  56. Green RH, Brightling CE, McKenna S, et al. Asthma exacerbations and sputum eosinophil counts: a randomized controlled trial. Lancet. 2002;360:1715–1721
  57. Lim KG, Mottram C. The use of fraction of exhaled nitric oxide in pulmonary practice. Chest. 2008;133:1232–1242
  58. Baptist AP, Sengupta R, Pranathiageswaran S, et al. Evaluation of exhaled nitric oxide measurements in the emergency department for patients with acute asthma. Ann Allergy Asthma Immunol. 2008;100:415–419
  59. Baptist AP, Shah B, Wang Y, et al. Exhaled nitric oxide levels during treatment in patients hospitalized with asthma. Allergy Asthma Proc. 2008;29:171–176
  60. Gibson PG, Simpson JL, Saltos N. Heterogeneity of airway inflammation in persistent asthma (Evidence of neutrophilic inflammation and increased sputum interleukin-8). Chest. 2001;119:1329–1336
  61. Ordonez CL, Shaughnessy TE, Matthay MA, et al. Increased neutrophil numbers and IL-8 levels in airway secretions in acute severe asthma. Am J Respir Crit Care Med. 2000;161:1185–1190
  62. Norzila MZ, Fakes K, Henry RL, et al. Interleukin-8 secretion and neutrophil recruitment accompanies induced sputum eosinophil activation in children with acute asthma. Am J Respir Crit Care Med. 2000;161:769–774
  63. Haldar P, Pavord ID. Noneosinophilic asthma: a distinct clinical and pathologic phenotype. J Allergy Clin Immunol. 2007;119:1043–1052
  64. Johnston SL, Blasi F, Black PN, et al. TELICAST Investigators The effect of telithromycin in acute exacerbations of asthma. N Engl J Med. 2006;354:1589–1600
  65. Simpson JL, Powell H, Boyle MJ, et al. Clarithromycin targets neutrophilic airway inflammation in refractory asthma. Am J Respir Crit Care Med. 2008;177:148–155
  66. De Palma AM, Vliegen I, De Clercq E, Neyts J. Selective inhibitors of picornavirus replication. Med Res Rev. 2008;28:823–884
  67. Castro M, Zimmerman NA, Crocker S, et al. Asthma intervention program prevents readmission in high healthcare users. Am J Respir Crit Care Med. 2003;168:1095–1099

 Funding: Parker B. Francis Fellowship Award and the National Institutes of Health (HL67850); National Health and Medical Research Council (NHMRC) Australia and an NHMRC Practitioner Fellowship award (PG); 21st Century Research Chair Program from the Government of Canada (BHR).

 Conflict of Interest: Dr Rowe has received research support and speaker's fees from GlaxoSmithKline (once: $1000) and AstraZeneca (multiple: ∼$3000/year) in the past 3 years; he is not a paid consultant or employee of either. Dr Gibson has received payment for expenses incurred in speaking at educational meetings in symposia sponsored by GlaxoSmithKline, AstraZeneca, and Novartis. Dr Gibson's institution has received research funding for studies from GlaxoSmithKline.

 Authorship: All authors had access to the data and played a role in writing this manuscript.

PII: S0002-9343(09)00160-0

doi: 10.1016/j.amjmed.2009.02.013

The American Journal of Medicine
Volume 122, Issue 11 , Pages 977-991 , November 2009

Article Tools